Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exherin in N-Cadherin Positive Solid Tumors
NCT00225550Phase 2Terminated
- Sponsor
- Adherex Technologies
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ADH-1 in solid tumor, sponsored by Adherex Technologies. Status: terminated.
02
Drugs
ADH-1
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT00225550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00225550.